DENNIS WOOLEY: Open Payments
NPI 1184628075 · COLUMBIA, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$773 in 44 payments from 11 companies in 2025. Trend: 2023 $153 · 2024 $286 · 2025 $773
Food & beverage: $773
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $192 |
| Alkermes, Inc. | 12 | $158 |
| Axsome Therapeutics, Inc. | 5 | $100 |
| AstraZeneca Pharmaceuticals LP | 4 | $77 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $62 |
| GlaxoSmithKline, LLC. | 3 | $52 |
| Vanda Pharmaceuticals Inc. | 2 | $44 |
| Amgen Inc. | 2 | $37 |
| Lilly USA, LLC | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
Products named: VRAYLAR, Auvelity, LYBALVI, ARISTADA, CAPLYTA, TRELEGY ELLIPTA, FANAPT, FARXIGA.
Industry payments across KY — which companies pay providers there.
